These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 27637307)

  • 41. Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism.
    Lim HY; Nandurkar H; Ho P
    Semin Thromb Hemost; 2018 Apr; 44(3):261-266. PubMed ID: 29558778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    Bajaj NS; Kalra R; Patel N; Hashim T; Godara H; Ather S; Arora G; Pasala T; Whitfield TT; McGiffin DC; Ahmed MI; Lloyd SG; Limdi NA; Arora P
    PLoS One; 2016; 11(10):e0163608. PubMed ID: 27706224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
    Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacologic Therapies in Anticoagulation.
    Ferreira JL; Wipf JE
    Med Clin North Am; 2016 Jul; 100(4):695-718. PubMed ID: 27235611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Vitamin K antagonist, direct oral anticoagulants: Where is the truth?].
    Laroche JP; Schved JF
    J Mal Vasc; 2016 Dec; 41(6):383-388. PubMed ID: 27817997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bridging therapy in oral anticoagulated patients: focusing on how to do it.
    Palareti G
    Intern Emerg Med; 2007 Dec; 2(4):247-9. PubMed ID: 18172591
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of bleeding complications in patients with cancer on DOACs.
    Schulman S; Shrum J; Majeed A
    Thromb Res; 2016 Apr; 140 Suppl 1():S142-7. PubMed ID: 27067968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct oral anticoagulants: unique properties and practical approaches to management.
    Barnes GD; Kurtz B
    Heart; 2016 Oct; 102(20):1620-6. PubMed ID: 27402803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Towards 'the best DOAC'?].
    van Doorn S; Rutten FH; Geersing GJ
    Ned Tijdschr Geneeskd; 2019 Mar; 163():. PubMed ID: 30945829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current challenges and future prospects in oral anticoagulant therapy.
    Czuprynska J; Patel JP; Arya R
    Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
    De Gottardi A; Trebicka J; Klinger C; Plessier A; Seijo S; Terziroli B; Magenta L; Semela D; Buscarini E; Langlet P; Görtzen J; Puente A; Müllhaupt B; Navascuès C; Nery F; Deltenre P; Turon F; Engelmann C; Arya R; Caca K; Peck-Radosavljevic M; Leebeek FWG; Valla D; Garcia-Pagan JC;
    Liver Int; 2017 May; 37(5):694-699. PubMed ID: 27778440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current and developing strategies for monitoring and reversing direct oral anticoagulants in patients with non-valvular atrial fibrillation.
    Sarma A; Giugliano RP
    Hosp Pract (1995); 2015; 43(5):258-67. PubMed ID: 26559852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of the SAMe-TT
    Zulkifly H; Lip GYH; Lane DA
    Heart Rhythm; 2018 Apr; 15(4):615-623. PubMed ID: 29180122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Age-dependency of prescribing patterns of oral anticoagulant drugs in Austria during 2011-2014.
    Schuh T; Reichardt B; Finsterer J; Stöllberger C
    J Thromb Thrombolysis; 2016 Oct; 42(3):447-51. PubMed ID: 27221106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New oral anticoagulants in elderly patients.
    Barco S; Cheung YW; Eikelboom JW; Coppens M
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):215-24. PubMed ID: 23953909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Proper use of oral anticoagulants in the elderly patient].
    Pautas E
    Soins Gerontol; 2023; 28(163):8-12. PubMed ID: 37716784
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
    Imberti D; Pomero F; Benedetti R; Fenoglio L
    Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
    Leung TS; Law EH
    Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism.
    Robert-Ebadi H; Righini M
    Ther Umsch; 2016; 73(10):618-625. PubMed ID: 28045360
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct factor Xa inhibitor edoxaban: from bench to clinical practice.
    Brekelmans M; Middeldorp S; Coppens M
    Expert Rev Hematol; 2015 Dec; 8(6):707-25. PubMed ID: 26560872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.